RUNX2 and nonpapillary renal cell carcinoma: Concurrently, both RUNX2 and MAPK11 are overexpressed in clear cell renal cell carcinoma (ccRCC) tissues and cell lines, enhancing the proliferation and migration of ccRCC cells [72].